Blueprint Medicines
BPMC
#2369
Rank
C$8.91 B
Marketcap
$140.32
Share price
-0.55%
Change (1 day)
72.79%
Change (1 year)

Blueprint Medicines (BPMC) - P/B ratio

P/B ratio as of November 2024 : 20.5

According to Blueprint Medicines 's latest financial reports the company has a price-to-book ratio of 14.7447.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Blueprint Medicines - P/B ratio (from 2015 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-3142.9742.97%
2022-12-315.09-21.55%
2021-12-316.4952.7%
2020-12-314.25-49.98%
2019-12-318.5050.03%
2018-12-315.677.87%
2017-12-315.2520.63%
2016-12-314.35-12.06%
2015-12-314.95
2014-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
1.95-90.49%๐Ÿ‡บ๐Ÿ‡ธ USA
0.7435-96.37%๐Ÿ‡บ๐Ÿ‡ธ USA
1.27-93.78%๐Ÿ‡บ๐Ÿ‡ธ USA